RxDoctor Payments Data

Raymond Tu, MD

Neuroradiology · Washington, DCNPI 1710961545

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,640 of the $3,656 with a category attached, or 72.2%. Merck accounts for 72.2% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $2,690 and has fallen 87.5% since, to $337 in 2025.

$3,656in general payments, 2019–2025

Across 6 payments — averaging $609.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$3K
  • United Imaging Healthcare North America LLC$569
  • Si-bone, Inc.$171
  • Boston Scientific$166
  • Teva Pharmaceuticals USA, Inc.$110

What the payments were for

  • Consulting fees$2,64072%
  • Travel & lodging$52014%
  • Food & beverage$49614%

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck1$2,640
United Imaging Healthcare North America LLC2$569
Si-bone, Inc.1$171
Boston Scientific1$166
Teva Pharmaceuticals USA, Inc.1$110

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few neuroradiology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$280,759
Medicare patients
2,657
Services billed
4,835

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neuroradiology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →